Main Symposia

Saturday 8 September
11.00 – 13.00

ESCRS/EuCornea Symposium: Corneal Neovascularisation

Chairpersons: R. Nuijts THE NETHERLANDS, H. Dua UK (EuCornea)

 

• 11.00
• P. Fagerholm SWEDEN               
  Mechanisms of neovascularisation
• 11.15
• D. Said UK
  Clinical aspects and assessment of corneal vascularisation
• 11.30
• Discussion
• 11.40
• C. Cursiefen GERMANY
  The medical management of corneal vascularisation
• 11.55
• L. Fontana ITALY
  The surgical management of corneal vascularisation in ocular surface disease
• 12.10
• Discussion
• 12.20
• J. Güell SPAIN  
  Pterygium and vascularisation: current concepts and therapeutic implications
• 12.35
• B. Seitz GERMANY               
  Corneal vascularisation in HSV keratopathy: implications for transplantation
• 12.50
• Discussion
• 13.00
• End of session

 

Saturday 8 September
14.00 – 16.00

ESCRS/EURETINA Symposium: Cataract surgery and macular disease

Chairpersons: P. Barry IRELAND, G. Richard GERMANY (EURETINA)

• 14.00
• S. Wolf SWITZERLAND
  Does cataract surgery accelerate conversion to wet AMD?
• 14.15
• F. Holz GERMANY
  Prophylactic anti-VEGF therapy in high risk dry and wet AMD
  at the time of cataract surgery?
• 14.30
• Discussion
• 14.40
• J. F. Korobelnik FRANCE
  Are multifocal IOLs contraindicated in AMD?
• 14.55
• F. Cuthbertson UK
  Do blue filter IOLs work?
• 15.10
• Discussion
• 15.20
• F. Bandello ITALY
  Diagnostic and treatment in diabetic macular oedema: an update
• 15.35
• M. Wilkins UK
  The intraocular telescope for AMD
• 15.50
• Discussion
• 16.00
• End of session

 

Sunday 9 September
11.00 – 13.00

ESCRS/WCPOS Symposium: Cataract and refractive surgery in children

Chairpersons: D. Epstein SWITZERLAND, K. K. Nischal USA/UK (WCPOS)

• 11.00
• R. Kekunnaya INDIA
  Do study design and surgical technique influence pediatric cataract study outcomes?
• 11.15
• E. Wilson USA
  Infant Aphakia Treatment Study
• 11.30
• Discussion
• 11.40
• C. Zetterström SWEDEN
  Clinical factors affecting target refraction in pediatric cataract surgery
• 11.55
• M.J. Tassignon BELGIUM
  Which IOLs are best in children's eyes?
• 12.10
• Discussion
• 12.20
• M. O'Keefe IRELAND
  Is there a role for phakic IOLs in the treatment of amblyopia?
• 12.35
• W. Astle CANADA
  Can the refractive surgeon help? PRK, LASEK and LASIK in children
• 12.50
• Discussion
• 13.00
• End of session

 

Monday 10 September
11.00 – 13.00

Femtosecond-assisted cataract surgery: Where are we now?

Chairpersons: M. Piovella ITALY, P. Rosen UK

• 11.00
• I. Pallikaris GREECE
  Imaging and capturing technology: how does it work?
• 11.15
• J. Stevens UK
  Delivery systems: How do they function?
• 11.30
• Real world clinical results and complications
  F. Bucci USA (LensAR)
  S. Daya UK (B&L Victus)
  B. Dick GERMANY (Optimedica)
  Z. Nagy HUNGARY (LensX Alcon)
• 12.00
• Discussion
• 12.10
• R. Lindstrom USA
  When will it work in private practice: what does it take to make it work?
• 12.25
• Discussion
• 12.35
• R. Bellucci ITALY
  When and how will it work in public practice?
• 12.50
• Discussion
• 13.00
• End of session

 

Tuesday 11 September
11.00 – 13.00

Innovations in IOL power calculation

Chairpersons: T. Kohnen GERMANY, R. Mencucci ITALY

• 11.00
• G. Auffarth GERMANY
  The gold standards: IOLMaster 500 and LenStar
• 11.15
• N. Rosa ITALY
  IOL power calculation in premium IOLs: part I (Accommodative/multifocal)
• 11.30
• Discussion
• 11.40
• J. Aramberri SPAIN
  IOL power calculation in premium IOLs: part II (Toric)
• 11.55
• W. Haigis GERMANY
  IOL power calculation after refractive surgery
• 12.10
• Discussion
• 12.20
• C. Carbonara ITALY
  New tools for biometry
• 12.35
• M. Mrochen SWITZERLAND
  The future: customised eye models
• 12.50
• Discussion
• 13.00
• End of session

 

Wednesday 12 September
11.00 – 13.00

I am a perfect cataract surgeon. How can I become better?

Chairpersons: R. Bellucci ITALY, M. Lundström SWEDEN

• 11.00
• D. Spalton UK
  How I avoid damaging the capsule
• 11.15
• J. Holladay USA
  How I always avoid refractive surprise
• 11.30
• Discussion
• 11.40
• R. Nuijts THE NETHERLANDS
  How I avoid inducing astigmatism
• 11.55
• C. Lobo PORTUGAL
  How I avoid cystoid macular oedema
• 12.10
• Discussion
• 12.20
• L. Buratto ITALY
  How I always avoid patient dissatisfaction
• 12.35
• K. Pesudovs AUSTRALIA
  I always evaluate patient benefits after cataract surgery
• 12.50
• Discussion
• 13.00
• End of session